(2S,3S)-diaminosuccinic acid

(2S,3S)-diaminosuccinic acid is a stereodefined diamino dicarboxylic acid featuring two primary amino groups and two carboxylic acid functionalities, making it a highly polar, strongly functional building block for chemical and materials workflows. Its fixed stereochemistry supports reproducible downstream derivatization, while the dense array of reactive amines and acids enables conversion into protected or activated intermediates used in peptide/peptidomimetic assembly, crosslinking chemistries, and analytical standard development.

1. Peptidomimetic Building Block

(2S,3S)-diaminosuccinic acid is used as a diamino dicarboxylate building block in peptidomimetic and peptide-analog synthesis, where incorporation of a rigid, polar linker segment is valuable for tuning charge distribution and hydrogen-bonding patterns in the resulting scaffold. Researchers in medicinal chemistry and chemical biology commonly select it when they need a defined stereochemical unit bearing two primary amines that can be differentially functionalized prior to coupling into larger constructs. Its dual-carboxylate motif also supports formation of amide or salt forms used to control solubility and handling during stepwise assembly of small-molecule mimics and peptide-like structures.

2. Bioconjugation Crosslinking Chemistry

(2S,3S)-diaminosuccinic acid serves as a practical reagent for constructing amine-rich linkers and for building crosslinkable motifs in bioconjugation workflows. Protein engineering groups and biomaterials researchers often rely on its two primary amino groups to introduce attachment points for coupling strategies that require stable amide formation or controlled nucleophile reactivity toward activated electrophiles. Because it is inherently multifunctional, it is frequently used to prepare intermediates that can be tethered to biomacromolecules (e.g., via activated carboxyl derivatives) or incorporated into polymer/particle surface modification schemes where multiple binding sites per linker are advantageous for achieving higher labeling density.

3. Chiral Derivatization Standard

(2S,3S)-diaminosuccinic acid is widely used in analytical chemistry as a stereodefined diamino acid reference for method development and characterization of chiral derivatization or separation workflows. Analytical laboratories employ it to evaluate derivatization efficiency and to confirm stereochemical outcomes when developing LC methods, capillary electrophoresis conditions, or mass spectrometric assays that distinguish stereoisomeric amino acid derivatives. The presence of two primary amines and two carboxyl groups provides multiple handles for forming consistent, detectable derivatives, supporting reproducible quantitation and identity checks during impurity profiling and analytical method validation of related amino acid derivatives.

4. Pharmaceutical Intermediate Development

(2S,3S)-diaminosuccinic acid is used as an intermediate platform in pharmaceutical intermediate development where a stereodefined diamino dicarboxylate unit is required for downstream functionalization. Process development and custom synthesis teams often choose it to generate activated derivatives (for example, amine- or carboxyl-functional intermediates) that can be carried into subsequent coupling, salt formation, or scaffold elaboration steps. Its strongly functional nature enables flexible transformation into a range of amide/urea-type linkages and other nitrogen-containing motifs used in the construction of research-stage lead compounds and specialized chemical libraries.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma